MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » 7 medtech stories we missed this week: Sept. 8, 2017

7 medtech stories we missed this week: Sept. 8, 2017

By

medtech missed
[Image from unsplash.com]
From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention.

1. BrainScope to develop pediatric traumatic brain injury assessment device

BrainScope announced in a Sept. 7 press release that it will immediately start creating a pediatric capability for its BrainScope One medical neurotechnology. The technology is an FDA-cleared handheld medical device that is designed to assess the full spectrum of traumatic brain injury. The company says that the pediatric version of its BrainScope One will be similar to the one that is currently available. The current device is easy-to-use and rapid and helps clinicians assess whether a patient has a structural brain injury that can be visible on a CT scan or if a patient has function brain impairment like a concussion.

2. BoneSupport inks French distribution deal

BoneSupport announced that it has signed a distribution deal with Novomedics, according to a Sept. 7 press release. The distribution deal intends to help BoneSupport gain access to the French market with its Cerament product line of bone void filler, Cerement G and Cerament V. The commercialization agreement allows for BoneSupport’s products to be sold in 8 key European markets while also directly marketing its products in five European countries in the U.K., Germany, Switzerland, Sweden and Denmark.

3. AliveCor touts Kardia study

AliveCor announced in a Sept. 6 press release the results of four clinical research presentations for its digital EKG, Kardia Mobile. Kardia is a hyperfast, 30-second digital EKG that uses artificial intelligence, mobile, cloud and microelectrode technology to help patients manage heart health. It helps patients and care teams easily, quickly and inexpensively detect and manage possible atrial fibrillation. The study found that people who used Kardia Mobile had a fourfold increase in atrial fibrillation detection. It also showed that the mobile device had an accuracy that was similar to what physicians can offer. It was able to detect more patients who had atrial fibrillation that had previously gone undiagnosed. The patients who participated in the study also reported that Kardia Mobile was easy to use.

4. Skyline Medical inks deal with Intalere for Streamway device

Skyline Medical has partnered with Intalere for Streamway System validation, according to a Sept. 5 press release. The contract states that Streamway will be incorporated into Intalere’s Innovation and New Technology category that will also indicate that Streamway demonstrates unique capabilities compared to other products on the market. The Streamway System was created by Skyline Medical and is FDA-approved for automated, direct-to-drain medical fluid disposal.

5. Delphinus launches SoftVue trial

Delphinus Medical Technologies announced in a Sept. 6 press release that it has launched its SoftVue Discover Breast Ultrasound Prospective Case Collection project and has enrolled the first patient. Those who are participating in the trial will undergo screening digital mammography and SoftVue 3D whole breast ultrasound exams. The information that is obtained from the study will compare SoftVue with digital mammography to determine how efficient SoftVue is with detecting additional cancers that can’t be seen with mammography, especially in women with dense breast tissue. The study plans to enroll 10,000 asymptomatic women who have dense breast tissue across the U.S.

6. C4 Imaging receives FDA nod for prostate cancer treatment

C4 Imaging has received FDA 510(k) clearance for its Sirius MRI Marker, according to a Sept. 5 press release. The device is designed to be a positive-signal MRI marker that is used during prostate cancer treatment with brachytherapy. The clearance allows for Sirius MRI Markers to be sterilized using ethylene oxide rather than gamma sterilization. Using ethylene oxide allows for increased convenience for customers and gives more benefits of MRI assisted brachytherapy to prostate cancer patients.

7. EOS Imaging launches spinal surgery planning software suite

EOS Imaging announced in a Sept. 5 press release that it has launched a new version of its spineEOS online 3D planning software for spinal surgery. SpineEOS uses biomechanics patient data for surgery simulation and helps physicians plan and optimize spinal treatment in patients. The planning software is based on EOS stereo radiographic 2D and 3D imaging.

In case you missed it

RSS From Medical Design & Outsourcing

  • They said it at DeviceTalks Boston
    Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead. Here are some of the most quotable insights from panelists and speakers at our live event. And make sure to save the date — and save your seat… […]
  • Summer health technology program brings diverse group of interns to Silicon Valley
    Diversity by Doing HealthTech (DxD) is holding a Summer Innovation and Exploration Series for college student interns from underrepresented groups. The series is on its second day today at Fogarty Innovation and Stanford Byers Center for Biodesign — the two organizations that jointly formed and support DxD. The event debuted last year in an online… […]
  • Clippard releases new series of isolation valves
    Clippard (Cincinnati) has Its Clippard NIV Series media isolation valve — a solenoid-operated device using a flexible diaphragm to isolate the actuation mechanism from the fluid path. Media isolation valves find everyday use in a wide variety of applications. Think uses that require precise, repeatable dispensing of media for analytical instrumentation. Clippard says media isolation… […]
  • Another Medtronic HVAD recall is serious
    A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving HeartWare Ventricular Assist Device pumps still implanted in patients. The FDA today designated a Medtronic recall involving the HVADs as Class I, the most serious level. It’s the second Class I recall designation for the HVADs this… […]
  • How SeaStar’s device calms hyperinflammation — and could prevent lasting damage from COVID cytokine storms
    SeaStar Medical recently won FDA breakthrough device designation for a new way to treat hyperinflammation with technology that could help fight chronic conditions from COVID-19 infections. The Denver-based medical developer is seeking a humanitarian device exemption for treating children with acute kidney injury (AKI) based on an FDA-funded study, SeaStar President and CEO Eric Schlorff… […]
  • How Avail Medsystems seeks to create a connected OR experience
    Much like a normal Starbucks-goer expects the coffee to taste a certain way at any location, Daniel Hawkins wants that type of experience in the operating room. Hawkins is the CEO of Avail Medsystems, a company developing telemedicine equipment that can connect surgeons, interventional specialists and medical device sales reps. Hawkins and the team at Avail… […]
  • How to leverage technology to drive diversity in clinical studies
    Convenience was the driver, and the traditional clinical trial model had to evolve when it came to a colorectal cancer screening study. The clinical study had 35,000 patients across the U.S. Chuanbo Xu, Freenome Cancer doesn’t discriminate. It’s the second-leading cause of death in the U.S. Early detection is key in treating — and even… […]
  • Medical device licensing pitfalls to avoid
    Prevent costly disputes caused by these common mistakes in patent license agreements. Marcelo Barros, Kathleen Daley, Brian Kacedon and Matthew Ritter, Finnegan Licensing and other technology transfer agreements can be critical for medical device companies that invest significantly into new technology R&D and seek and obtain intellectual property protection for those investments. But if these agreements… […]
  • Tolerance stack-up: Insight into the inner workings of high-density microelectronic medical devices
    Tolerance stack-up is a defining design concept to ensure new products are built efficiently and effectively.  Darren Gilmer, Intricon At a time when the future of micro-miniature medical devices seems unlimited, one fundamental reality remains firmly in place — the sizes and shapes of human anatomy. From blood vessels to ear canals, respiratory passages to… […]
  • Deburring and finishing for beautiful, functional medical devices
    The latest automated cutting tools help medical device manufacturers meet strict specs and high demand. Dave Sawicki, Xebec Increasing demand and advances in technology are driving growth in the medical device industry. Chronic diseases are more prevalent, and the aging population is larger, contributing to the demand for highly regulated Class III medical devices such… […]
  • FDA seeking innovations to move beyond heater-cooler device problems
    The FDA issued a notice today saying that it is working to evaluate new strategies to mitigate infections associated with heater-cooler devices. According to the notice, the administration is collaborating with professional societies, public health partners, heater-cooler manufacturers, and experts on the matter surrounding the heater-cooler devices used during medical and surgical procedures to warm… […]